Clinical Trials
FDA Approval of AMVUTTRA for ATTR Amyloidosis
Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics, has announced U.S. FDA approval of AMVUTTRA® (vutrisiran) for the treatment of cardiomyopathy associated with...
Clinical Trials
Rina-S Shows Promise in Advanced Ovarian Cancer
Genmab has reported encouraging findings from the Phase 2 RAINFOL-01 trial of rinatabart sesutecan (Rina-S®), an experimental folate receptor-alpha (FRα)-targeted, TOPO1 antibody-drug combination (ADC)....
News
Pharma Support Powers Sofinnova Biotech Acceleration Fund
Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong Pharma Support
European life sciences investment firm Sofinnova Partners has announced the final close of its...
Industry Reports
Regenerative Medicine Makeover Via Artificial Intelligence
While the regenerative medicine spectrum continues its upward trend, artificial intelligence incorporation happens to be playing a role that’s especially transformative in the pharmaceutical...
Clinical Trials
Artificial Intelligence – Giving Clinical Trial A Facelift
Across the past so many years, there have been pharmaceutical companies that have been integrating artificial intelligence steadily into many elements of clinical development....
BioPharma
Pharmaceutical Contract Sales Market to Hit $26.24B by 2034
Contract Sales Organizations: Transforming Pharma Companies
Contract sales organizations – CSOs are becoming vital tools for pharmaceutical companies to boost sales performance while keeping marketing...
IT & Data Management
AI-Driven Small Molecule Therapies for I&I Diseases
AI Advances Small Molecule Therapies for I&I Diseases
Driven by artificial intelligence, drug development is proceeding against incentives from the Inflation Reduction Act and also...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read